Syncona Portfolio

Latest statistics and disclosures from Syncona Portfolio's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ACHL, AUTL, FRLN, ADAP, and represent 100.00% of Syncona Portfolio's stock portfolio.
  • Added to shares of these 1 stocks: FRLN (+$5.1M).
  • Syncona Portfolio was a net buyer of stock by $5.1M.
  • Syncona Portfolio has $105M in assets under management (AUM), dropping by -0.00%.
  • Central Index Key (CIK): 0001725042

Tip: Access up to 7 years of quarterly data

Positions held by Syncona Portfolio consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Syncona Portfolio

Companies in the Syncona Portfolio portfolio as of the March 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Achilles Therapeutics Sponsored Ads (ACHL) 53.1 $56M 11M 5.01
Autolus Therapeutics Spon Ads (AUTL) 36.4 $38M 7.3M 5.19
Freeline Therapeutics Hldgs Sponsored Ads (FRLN) 5.6 $5.8M +645% 22M 0.27
Adaptimmune Therapeutics Sponds Adr (ADAP) 4.9 $5.2M 1.4M 3.75

Past Filings by Syncona Portfolio

SEC 13F filings are viewable for Syncona Portfolio going back to 2021